Sensible policy on psychedelic drugs is growing more common
They show tremendous potential in treating certain mental-health disorders | United States
Source: economist.com
📰 Compass Pathways News
Page 31 - Compass Pathways News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Compass Pathways. Real-time updates on events, politics, business and more.
Psychedelic biotech Eleusis enters SPAC deal to take depression drug to the clinic
Eleusis is developing a formulation of the psychedelic compound psilocybin that overcomes limitations of pill versions of the drug. Depression is Eleusis’s lead disease target but the biotech notes that its research has shown the potential to bring psychedelic drugs beyond psychiatry.
Source: medcitynews.com
Microsmallcap.com: Psilocybin and MDMA Get the Green Light for Medical Use in Canada
FN Media Group Presents Microsmallcap.com Market Commentary NEW YORK, Jan. 19, 2022 /PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received
United Kingdom Robert Barrow Kostenloser Wertpapierhandel Numinus Bioscience Therapeutics Ltd Drug Administration
Source: finanznachrichten.de
Investegate |COMPASS Pathways Announcements | COMPASS Pathways: Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression
Investegate announcements from COMPASS Pathways, Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with treatment-resistant depression
Source: investegate.co.uk
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
/PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical...
United Kingdom Robert Barrow Numinus Bioscience Therapeutics Ltd Drug Administration Public Benefit Corporation
Source: prnewswire.com
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
/PRNewswire/ -- After facing legal scrutiny for decades, psychedelics including MDMA and psilocybin received a stamp of approval from Health Canada for medical...
United Kingdom Robert Barrow Numinus Bioscience Therapeutics Ltd Drug Administration Public Benefit Corporation
Source: prnewswire.com
Rollups: The Emerging Magic Mushroom Monopoly
Compass Pathways has been aggressively using patent claims to corner the market on psychedelic-assisted treatments.
Source: prospect.org
Psilocybin clinical trial confirms safety of group psychedelic sessions
A study is reporting the results of a clinical trial testing the safety of administering psilocybin in a group setting. Exploring the psychedelic therapy in groups of up to six, the trial found no adverse effects from simultaneous drug administration.
Source: newatlas.com
Charlotte Nichols MP asks Prime Minister question in Parliament
ONE of Warrington’s MPs put a question to the Prime Minister in the House of Commons this afternoon, Wednesday.
Source: warringtonguardian.co.uk
BBCNEWS HARDtalk January 5, 2022 15:40:00
100th birthday.— centenarian edna a very very happy 100th birthday. tasha, mr speaker. groundbreaking _ 100th birthday. tasha, mr speaker. groundbreaking research _ 100th birthday. tasha, mr speaker. groundbreaking research published| groundbreaking research published yesterday in the journal of psychopharmacology from kings college — psychopharmacology from kings college london in partnership with compass _ college london in partnership with compass pathways has now established that silos _...
Centenarian Edna A Compass Pathways 100th Birthday Groundbreaking Research Groundbreaking Research Published 100th Birthday
Source: archive.org